Back to
Hudson Bay Capital Management LP
TARS
2 quarters
Position history for
Hudson Bay Capital Management LP's holdings in Tarsus Pharmaceuticals, Inc.
No. Hudson Bay Capital exited its TARS (Tarsus Pharmaceuticals) position in Q3 2024. Its Q2 2024 13F listed 85,000 shares worth $2.3M. Hudson Bay Capital first reported TARS in Q2 2024 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$2.3M
Total Shares Change
-85,000
Quarter-by-Quarter History
Other major holders of TARS: BlackRock, Inc., RTW Investments, LP